Definitive Contract 75A50122C00070

Award Date 9/30/22
Potential Completion Date 5/20/28
Potential Value $65M
Ultimate Awardee
Danaher Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Sharing
Place of Performance
West Sacramento, CA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $379,924.67 firm-fixed-price definitive contract awarded by the Air Mobility Command (AMC) to Beckman Coulter, Inc., a subsidiary of Danaher Corporation, for a Microbiology Identification and Susceptibility Analyzer and Reagents. The contract has a completion date of September 30, 2021 and was awarded on March 31, 2016. This award was not set aside for small businesses. Beckman Coulter is a global manufacturer of biomedical testing equipment, laboratory instruments, reagents, software,...
This is a $406,514.30 firm fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response to Beckman Coulter, Inc., a subsidiary of Danaher Corporation, for an R&D effort to develop a rapid detection method for severe, dysregulated host immune responses to infection in pediatric patients. The contract is not set aside for any specific business category. The contract supports the Major Program Code "BECKMAN COULTER: MDW FOR RAPID DETECTION OF...
This is a $213,540.00 firm fixed price delivery order contract awarded by the Defense Health Agency to Beckman Coulter, Inc., a subsidiary of Danaher Corporation, for the provision of susceptibility panels. The contract has an ultimate completion date of September 30, 2027 and was awarded on October 1, 2022. The contract is not set aside and is awarded under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule, which enables federal healthcare facilities to acquire...
This federal contract award to Beckman Coulter, Inc. is for a "Cost Per Test Agreement" under GSA Schedule Contract Critical Analyzers, Laboratory (FSS-66-III). The $129,392.64 firm fixed-price delivery order was awarded by the Bureau of Medicine and Surgery, a defense agency, to provide clinical laboratory equipment, reagents, and services. The contract does not have a set-aside designation. Beckman Coulter, a subsidiary of Danaher Corporation, is the prime contractor. The company has...
This federal contract award, valued at $77,399.64, was made by the Centers for Disease Control and Prevention (CDC) to Beckman Coulter, Inc., a subsidiary of Danaher Corporation, for the provision of laboratory equipment to support the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) in its COVID-19 response efforts. The contract was issued as a purchase order without any set-aside designations, indicating Beckman Coulter's unique capabilities in this specialized area....
This is a firm-fixed-price delivery order awarded by the Bureau of Medicine and Surgery, a Defense agency, to Beckman Coulter, Inc., a subsidiary of Danaher Corporation. The $139,416.00 contract is for a "COST PER TEST AGREEMENT" under the Critical Analyzers, Laboratory (FSS-66-III) GSA schedule. The award does not have a set-aside designation. Beckman Coulter, a manufacturer of clinical laboratory equipment, reagents, and services, has held numerous federal contracts to supply...
This federal contract award is for a delivery order issued by the Department of Health and Human Services Indian Health Service to Beckman Coulter, Inc. The contract is for $169,792.02 and is for the provision of microbial and susceptibility testing services. The contract was awarded on a firm fixed price basis and has a completion date of March 19, 2023. Beckman Coulter, Inc. is a subsidiary of Danaher Corporation, a manufacturer of clinical laboratory equipment, reagents, and services. Beckman...
This federal contract award was made by the Department of Defense's Bureau of Medicine and Surgery (BUMED) to Beckman Coulter, Inc.'s US Customer Operations Division, a subsidiary of Danaher Corporation. The $70,804.20 Firm Fixed Price Delivery Order contract is for a "Cost Per Test Agreement" under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule. The contract has an ultimate completion date of September 30, 2016. Beckman Coulter, a manufacturer of clinical laboratory...
This is a firm fixed-price purchase order awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Beckman Coulter, Inc. for a microbiology analyzer at a total potential value of $137,031.84. The contract has no set-aside designation. Beckman Coulter, Inc. is a subsidiary of Danaher Corporation, which has a history of providing clinical laboratory equipment, reagents, and services to federal agencies including the Department of Veterans Affairs and Defense Health Agency. This...
This is a $80,518.75 Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) to Beckman Coulter, Inc. for the provision of microbiology tests on a cost-per-reportable result basis. The contract has a period of performance through February 20, 2019 and was awarded under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule. This contract does not have a set-aside designation. Beckman Coulter, a subsidiary of Danaher Corporation, is a manufacturer of...

This is a $65,183,092 cost-sharing contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Beckman Coulter, Inc. to develop and commercialize a rapid antimicrobial susceptibility testing system that can deliver results within 4-6 hours. The contract has a performance period ending on May 20, 2028. Beckman Coulter, a subsidiary of Danaher Corporation, has previously been awarded federal contracts to provide clinical laboratory technologies, supplies, and services to agencies like the Department of Veterans Affairs and Defense Health Agency. This contract was originated from a Broad Agency Announcement issued by BARDA seeking advanced research and development of medical countermeasures for chemical, biological, radiological, nuclear, and pandemic influenza threats. The contract does not have a set-aside designation.

Generated 10/26/24, 10:43 AM